|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.85 USD | +1.14% |
|
+6.58% | +12.73% |
| Jul. 16 | Kalshi to allow bets on clinical trials, FDA decisions | RE |
| Jul. 15 | African markets - factors to watch on July 15 | RE |
| Market Cap | 169B 148B 137B 126B 238B 16,306B 242B 1,631B 641B 7,963B 636B 622B 27,492B | P/E 2026 * |
-49.1x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 179B 156B 144B 133B 251B 17,218B 255B 1,723B 677B 8,408B 671B 656B 29,028B | EV / Sales 2026 * |
5.86x | EV / Sales 2027 * | 5.22x |
| Free-Float |
99.88% | Yield 2026 * |
2.38% | Yield 2027 * | 2.47% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +1.54% | ||
| 1 week | +6.37% | ||
| Current month | +9.30% | ||
| 1 month | +10.08% | ||
| 3 months | +0.33% | ||
| 6 months | +11.24% | ||
| Current year | +12.51% |
| 1 week | 127.94 |  | 140.61 |
| 1 month | 122.43 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 107.75 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 6/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 6/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.60% | +6.37% | +26.93% | +78.23% | 169B | |
| +1.22% | -0.76% | +54.90% | +163.80% | 1,043B | |
| +1.48% | -1.45% | +55.39% | +59.21% | 602B | |
| +1.59% | +3.73% | +34.45% | +90.86% | 449B | |
| +0.44% | -0.92% | +29.77% | +24.35% | 327B | |
| +0.85% | -0.06% | +33.06% | +46.26% | 279B | |
| -0.01% | -1.98% | +21.99% | +23.33% | 264B | |
| +0.18% | +2.47% | +24.85% | +63.44% | 201B | |
| +0.78% | +4.78% | +2.91% | -29.46% | 143B | |
| +0.84% | +1.05% | +5.88% | +37.02% | 123B | |
| Average | +0.83% | -0.83% | +29.01% | +55.70% | 360.04B | |
| Weighted average by Cap. | +0.96% | -1.83% | +39.30% | +83.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.47B 26.63B 24.63B 22.6B 42.78B 2,936B 43.52B 294B 115B 1,434B 114B 112B 4,950B | 32.4B 28.32B 26.19B 24.03B 45.49B 3,122B 46.28B 312B 123B 1,525B 122B 119B 5,263B |
| Net income | -3.39B -2.96B -2.74B -2.52B -4.76B -327B -4.84B -32.69B -12.84B -160B -12.73B -12.45B -551B | 9.76B 8.53B 7.89B 7.24B 13.7B 941B 13.94B 94.11B 36.97B 459B 36.66B 35.85B 1,586B |
| Net Debt | 9.46B 8.27B 7.65B 7.02B 13.28B 912B 13.51B 91.2B 35.83B 445B 35.53B 34.75B 1,537B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | $138.32 | +1.48% | 2,194,709 |
| 26-07-16 | $136.30 | +3.49% | 7,926,819 |
| 26-07-15 | $131.70 | +1.28% | 4,467,637 |
| 26-07-14 | $130.04 | -1.04% | 5,255,960 |
| 26-07-13 | $131.40 | +1.21% | 5,131,594 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
